Literature DB >> 6118870

Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide.

A Goldstein, W Fischli, L I Lowney, M Hunkapiller, L Hood.   

Abstract

The full primary structure of the very potent opioid peptide dynorphin, from porcine pituitary, has been determined. It is (H)Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln(OH). The synthetic peptide with this sequence behaves identically to natural dynorphin in a number of ways, and it has the same potency in the guinea pig ileum myenteric plexus--longitudinal muscle bioassay. The potency is accounted for by the first 13 residues.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118870      PMCID: PMC349228          DOI: 10.1073/pnas.78.11.7219

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties.

Authors:  B M Cox; K E Opheim; H Teschemacher; A Goldstein
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

2.  A pituitary endorphin with novel properties.

Authors:  L I Lowney; S B Gentleman; A Goldstein
Journal:  Life Sci       Date:  1979-06-18       Impact factor: 5.037

3.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

Review 4.  In vitro models in the study of structure-activity relationships of narcotic analgesics.

Authors:  H W Kosterlitz; A A Waterfield
Journal:  Annu Rev Pharmacol       Date:  1975       Impact factor: 13.820

5.  Human chorionic gonadotropin. Linear amino acid sequence of the beta subunit.

Authors:  R B Carlsen; O P Bahl; N Swaminathan
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

6.  Specific receptor for the opioid peptide dynorphin: structure--activity relationships.

Authors:  C Chavkin; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

7.  Immunoreactive dynorphin in pituitary and brain.

Authors:  A Goldstein; V E Ghazarossian
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

8.  Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus.

Authors:  C Chavkin; A Goldstein
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

9.  The amino-acid sequence of leghemoglobin component a from Phaseolus vulgaris (kidney bean).

Authors:  P Lehtovaara; N Ellfolk
Journal:  Eur J Biochem       Date:  1975-06

10.  Snake venom toxins. The purification of toxins VII1 and VII2, two cytotoxin homologues from banded Egyptian cobra (Naja haje annulifera) venom, and the complete amino acid sequence of toxin VII1.

Authors:  K H Weise; F H Carlsson; F J Joubert; D J Strydom
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973 Oct-Nov
View more
  59 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 2.  Dynorphin A analogs for the treatment of chronic neuropathic pain.

Authors:  Sara M Hall; Yeon Sun Lee; Victor J Hruby
Journal:  Future Med Chem       Date:  2016-01-29       Impact factor: 3.808

3.  75 years of opioid research: the exciting but vain quest for the Holy Grail.

Authors:  Alistair D Corbett; Graeme Henderson; Alexander T McKnight; Stewart J Paterson
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 4.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

5.  "DAKLI": a multipurpose ligand with high affinity and selectivity for dynorphin (kappa opioid) binding sites.

Authors:  A Goldstein; J J Nestor; A Naidu; S R Newman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Chimeric opioid peptides: tools for identifying opioid receptor types.

Authors:  G X Xie; A Miyajima; T Yokota; K Arai; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

7.  Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

Authors:  I Christensson-Nylander; M Herrera-Marschitz; W Staines; T Hökfelt; L Terenius; U Ungerstedt; C Cuello; W H Oertel; M Goldstein
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

8.  Neuropeptide Y: complete amino acid sequence of the brain peptide.

Authors:  K Tatemoto
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Increased spinal prodynorphin gene expression in reinflammation-associated hyperalgesia after neonatal inflammatory insult.

Authors:  Jack Yu-Shih Lin; Yu-Che Cheng; Julia Yi-Ru Chen; Chih-Cheng Chien; Shih-Chang Lin; Yeong-Ray Wen; Tsung-Shan Tsou; Qing-Dong Ling
Journal:  BMC Neurosci       Date:  2010-10-25       Impact factor: 3.288

Review 10.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.